Many women with Type 1 Diabetes struggle with sexual health issues, but the full picture was often unclear. A new systematic review and meta-analysis looked at data from 2,476 women to understand this problem better. The study compared women with Type 1 Diabetes to age-matched controls and to women with Type 2 Diabetes. It found that the risk of female sexual dysfunction was much higher in the Type 1 Diabetes group. Specifically, the risk was 2.10 times higher than in healthy controls. Women with Type 1 Diabetes also faced a higher incidence of these issues compared to those with Type 2 Diabetes. The review used standard cut-off scores to measure dysfunction and found a prevalence of about 34% in the Type 1 Diabetes group. This means roughly one in three women in this group experienced these symptoms. The study highlights a significant gap in care for this population. While the data is strong, the researchers noted some limitations. They often excluded older populations and did not always compare different subtypes of diabetes. These gaps mean the full story for every woman remains incomplete. Despite these limits, the findings are clear. Comprehensive care strategies that address both the physiological and psychological aspects of Type 1 Diabetes are warranted to improve sexual health and overall well-being in affected women.
Women with Type 1 Diabetes have a 2.10 times higher risk of female sexual dysfunction compared to age-matched controlsWomen with Type 1 Diabetes face a higher risk of sexual dysfunction than controls
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This systematic review and meta-analysis examined the prevalence and risk of female sexual dysfunction (FSD) in women with Type 1 Diabetes. The analysis included 2476 participants across multiple studies. The pooled prevalence of FSD in adults with Type 1 Diabetes was 37% (95% CI: 30%, 43%). When using a standard FSFI cut-off of less than or equal to 26.5, the prevalence was 34% (95% CI: 26%, 41%).
The risk of FSD in women with Type 1 Diabetes versus age-matched controls was higher, with an adjusted Risk ratio of 2.10 (95% CI: 1.30, 3.39; p = 0.002). The incidence of FSD in Type 1 Diabetes versus Type 2 Diabetes was also higher, with a p-interaction value of less than 0.01. Heterogeneity was noted in the pooled estimates.
The authors identified limitations including the frequent exclusion of older populations and the failure to compare diabetes subtypes in certain analyses. Comprehensive care strategies that address both the physiological and psychological aspects of Type 1 Diabetes are warranted to improve sexual health and overall well-being in affected women.